Johnson & Johnson’s COVID-19 vaccine works well against the delta variant and the immune response lasts at least eight months, the company said on Thursday, according to NBC News.
“Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane,” Dr. Mathai Mammen, global head of Janssen Research & Development, Johnson & Johnson, said in a news release. “Rather, we observe an improvement over time.”
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)